In toxicology, epigenetic biomarkers are employed to assess exposure and predict potential health outcomes. These biomarkers can indicate the extent of exposure to particular toxins and help in identifying susceptible populations. For example, alterations in DNA methylation profiles can serve as early indicators of exposure to carcinogens, allowing for timely intervention. Moreover, these biomarkers are instrumental in understanding the mechanisms of toxicity and developing new strategies for risk assessment and management.
